Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
Cheng Wei(Tianjin Medical University General Hospital), Jianning Zhang(Tianjin University of Technology), Ze‐Sheng Li(Tianjin Medical University General Hospital), Yingjie He(Southern University of Science and Technology), Lin Luo(Minjiang University), Hao Liang(Jinan University), Xiaoyang Zhang(University of Utah), Dazhao Peng(Tianjin Medical University General Hospital), Bo Wang(Peking University), Shenghui Li(Taixing People's Hospital), Lei Han(Indiana University – Purdue University Indianapolis), Shu Zhang(BGI Group (China)), Zhenyu Zhang(Dalian Medical University), Xuezhi Du(Second Hospital of Tianjin Medical University)
Cited by 104
Related Papers
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
|Cancer Cell|2018|1.2k
The RNA modification database, RNAMDB: 2011 update
|Nucleic Acids Research|2010|829